GlobeNewswire Inc | Sep 3, 2020 08:00AM EDT

September 03, 2020

NEW YORK, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announcedthat Mark Pruzanski, M.D., President and Chief Executive Officer and Sandip Kapadia, Chief Financial Officer of Intercept, will present at the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, September 9, 2020 at 12:00 p.m. ET.

A live webcast of the event will be available on the investor page of Intercepts website at http://ir.interceptpharma.com. An audio archive of the webcast will also be available on Intercepts website for approximately two weeks.

The company will also host meetings at Bairds 2020 Global Healthcare Conference on September 9, 2020 and Citis Annual BioPharma Virtual Conference on September 10, 2020.

About Intercept Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visitwww.interceptpharma.comor connect with the company onTwitterandLinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries:investors@interceptpharma.com

Media inquiries:media@interceptpharma.com